Dexus enters JV to set up healthcare fund
Dexus has entered into a joint venture agreement (JV) with Commercial & General (C&G) to establish a new wholesale unlisted healthcare fund.
Under the terms of the deal, Dexus and C&G would co-invest in the fund and would set up a jointly owned investment manager, with Dexus’ initial co-investment of approximately $80 million.
The responsible entity (RE) of the new Australian Healthcare Property Fund would be wholly owned by Dexus as part of the group’s funds management platform.
Also, the new fund would be seeded with $370 million worth of properties, including the Adelaide Calvary Hospital and GP Plus Healthcare Centre in Adelaide.
Dexus said that healthcare property presented an opportunity for the company to drive long-term returns through leveraging capabilities of its platform across transactions, development, leasing and investment management.
Dexus’ chief executive, Darren Steinberg, said: “We are pleased to partner with C&G and look forward to continuing to build scale in the growing healthcare sector which will benefit from the underlying mega-trends of population growth and an ageing demographic”.
“We see this property asset class as a logical extension to our funds management platform.”
Marketing of the new fund would start in July with a view to launching the fund by the end of 2017, the company said.
AUTHOR
Oksana Patron
Recommended for you
The $673 billion global investment manager has appointed a former Zenith sales head as it seeks to expand its reach in the Australian wealth management market.
Fund managers may be operating in a squeezed environment, but a salary guide shows they are willing to pay up for specialist talent to diversify their fund range.
Reach Alternative Investments has entered into a strategic partnership with Russell Investments to bolster its wholesale private markets offering for financial advisers and investors.
Boutique investment consulting and research house Genium Investment Partners has announced a senior appointment to drive further growth in its research ratings business.
